Brief: Equasens FY Revenue Up At EUR 214.1 Mln
Feb 3 (Reuters) - Equasens SA EQSE.PA :
* FOR 2023, AFTER SUCCESSFULLY STRENGTHENING ITS POSITIONS
IN UK
(CAREMEDS) AND GERMANY(I-MEDS), GROUP MAINTAINS ITS GOALS FOR
EXPANSION IN EUROPE AND DEVELOPMENT IN OTHER AREAS OF
HEALTHCARE.
* FY 2022 REVENUE €214.07M, UP +10.88%
Source text for Eikon: ID:nGNE2CCjX4
Further company coverage: EQSE.PA
(Gdansk Newsroom)
(( gdansk.newsroom@thomsonreuters.com ; +48 58 769 66 00; ))
Recent news on Equasens SA
See all newsFrance's Equasens H1 profit up 10.5%, helped by acquisitions
French and Benelux stocks-Factors to watch Sept 23
Brief: Equasens Activates Business Continuity Plan After Fire In Its Subsidiary Asca In Chessy
France's Equasens H1 revenue rises on growth in maintenance and subscription businesses
Brief: Equasens H1 Revenue EUR 124.5 Mln